Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:21 pm Sale | 2024-12-31 | 13G | SURROZEN INC SRZN | Alyeska Investment Group, L.P. | 26,855 0.800% | -161,853 (-85.77%) | Filing History |
| 2024-11-14 4:40 pm Sale | 2024-09-30 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Alyeska Investment Group, L.P. | 0 0.000% | -1,830 (Position Closed) | Filing History |
| 2024-11-14 4:39 pm Sale | 2024-09-30 | 13G | BLUEBIRD BIO INC BLUE | Alyeska Investment Group, L.P. | 0 0.000% | -345,625 (Position Closed) | Filing History |
| 2024-11-14 4:38 pm Sale | 2024-09-30 | 13G | APPLIED THERAPEUTICS INC APLT | Alyeska Investment Group, L.P. | 4,981,673 4.200% | -2,733,524 (-35.43%) | Filing History |
| 2024-11-14 4:37 pm Sale | 2024-09-30 | 13G | ALIGOS THERAPEUTICS INC ALGS | Alyeska Investment Group, L.P. | 146,472 4.800% | -140,599 (-48.98%) | Filing History |
| 2024-11-14 4:36 pm Purchase | 2024-09-30 | 13G | VERASTEM INC VSTM | Alyeska Investment Group, L.P. | 2,859,954 7.110% | 2,859,954 (New Position) | Filing History |
| 2024-11-14 4:35 pm Sale | 2024-09-30 | 13G | UNITY BIOTECHNOLOGY INC NE UNBX | Alyeska Investment Group, L.P. | 1,667,914 9.990% | -8,904 (-0.53%) | Filing History |
| 2024-11-14 4:34 pm Sale | 2024-09-30 | 13G | SURROZEN INC SRZN | Alyeska Investment Group, L.P. | 188,708 5.800% | -14,921 (-7.33%) | Filing History |
| 2024-11-14 4:33 pm Purchase | 2024-09-30 | 13G | P3 HEALTH PARTNERS INC PIII | Alyeska Investment Group, L.P. | 16,014,443 9.990% | 16,014,443 (New Position) | Filing History |
| 2024-11-14 4:32 pm Purchase | 2024-09-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | Alyeska Investment Group, L.P. | 256,408 8.400% | 256,408 (New Position) | Filing History |
| 2024-11-14 4:31 pm Purchase | 2024-09-30 | 13G | INTELLIGENT BIO SOLUTIONS INC INBS | Alyeska Investment Group, L.P. | 42,073 9.990% | 42,073 (New Position) | Filing History |
| 2024-11-14 4:30 pm Purchase | 2024-09-30 | 13G | GUARDIAN PHARMACY SVCS INC CL GRDN | Alyeska Investment Group, L.P. | 428,570 5.400% | 428,570 (New Position) | Filing History |
| 2024-11-14 4:29 pm Purchase | 2024-09-30 | 13G | FIVE9 INC FIVN | Alyeska Investment Group, L.P. | 4,400,256 5.900% | 4,400,256 (New Position) | Filing History |
| 2024-02-14 1:55 pm Purchase | 2023-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Alyeska Investment Group, L.P. | 1,830 9.990% | 1,830 (New Position) | Filing History |
| 2024-02-14 1:55 pm Purchase | 2023-12-31 | 13G | SURROZEN INC SRZN | Alyeska Investment Group, L.P. | 203,629 9.990% | 203,629 (New Position) | Filing History |
| 2024-02-14 1:54 pm Purchase | 2023-12-31 | 13G | NEMAURA MED INC NMRD | Alyeska Investment Group, L.P. | 2,887,050 9.990% | 2,887,050 (New Position) | Filing History |
| 2024-02-14 1:54 pm Purchase | 2023-12-31 | 13G | BLUEBIRD BIO INC BLUE | Alyeska Investment Group, L.P. | 345,625 6.320% | 345,625 (New Position) | Filing History |
| 2024-02-14 1:53 pm Purchase | 2023-12-31 | 13G | ALIGOS THERAPEUTICS INC ALGS | Alyeska Investment Group, L.P. | 287,071 9.990% | 287,071 (New Position) | Filing History |
| 2024-02-14 1:52 pm Purchase | 2023-12-31 | 13G | UNITY BIOTECHNOLOGY INC NE UNBX | Alyeska Investment Group, L.P. | 1,676,818 9.990% | 257,818 (+18.17%) | Filing History |
| 2024-02-14 1:51 pm Sale | 2023-12-31 | 13G | MEDAVAIL HLDGS INC MDVL | Alyeska Investment Group, L.P. | 87,618 5.430% | -72,472 (-45.27%) | Filing History |